SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Swedish manufacturing: special report

‘Embarrassment’ holding back green manufacturing, says Sweden

Sweden’s pharmaceutical regulator is pushing hard to make water pollution regulations a binding part of GMP, and says “embarrassed” European agencies are dragging their feet more than big pharma.

Blue and yellow make green? Not yet in Sweden say experts

Baxter recalls broken saline vials

Baxter has recalled two batches of saline injections after healthcare workers noticed parts of the vial had broken into the product.

AstraZeneca API plant set to shut by 2017 as Patent Cliff strikes again

An AstraZeneca API plant in Bristol, UK will close its doors within two years due to patent expirations of its cholesterol-lowering blockbuster Crestor.

API supplier issues again cause FDA to reject Pozen drug candidates

For the second time the US FDA has rejected two versions of Pozen’s investigational drug candidate because of issues with a supplier’s foreign manufacturing facility.

News in brief

US FDA issues Form 483 to Hovione API facility in Portugal

The US FDA’s pre-approval inspection at Hovione’s API plant in Loures, Portugal, covering two NDA filings, resulted in a Form 483 with three inspectional observations. 

Immunotherapy in the UK? National manufacturing site backed by GE

GE Healthcare has pledged its support and technology to a national £55m ($86m) Cell Therapy manufacturing centre in Stevenage, UK, set to launch in 2017.

Rouble trouble: Big Pharma exposure to Russian currency volatility limited

Big Pharma firms’ exposure to Russia’s volatile rouble is limited and planned manufacturing investments will go ahead according to observers.

Spotlight

Axim to build Dutch facility for cannabinoid-based chewing gum drug

Axim to build Dutch facility for cannabinoid-based chewing gum drug

A company developing a pharmaceutical chewing gum containing cannabinoids extracted from marijuana has announced plans to build...

Two INDs or not two INDs? Unanswered questions in China draft MRCT guide

Two INDs or not two INDs? Unanswered questions in China draft MRCT guide

Drugmakers that include China in multi-regional trials will need to submit dossiers filed elsewhere for review, open...

Advanced aspirin aspirations ailing? Sanofi and Pozen terminate deal

Advanced aspirin aspirations ailing? Sanofi and Pozen terminate deal

Sanofi and Pozen have dissolved a $35m (Eur28m) ‘advanced aspirin’ partnership less than a month before the...

Want to relocate to Asia? What pharma recruiters really look for

Want to relocate to Asia? What pharma recruiters really look for

Singaporean companies are looking for scientists, while China and India need execs – but don’t count on...

Chinese excipient market set to more than double by 2017

Chinese excipient market set to more than double by 2017

With more than 90 excipient manufacturers in China dedicated to the pharma industry, the country expects its...

BASF sells Norway plant, focuses on pharma grade omega-3 products

BASF sells Norway plant, focuses on pharma grade omega-3 products

BASF says the supply of API to GSK and other pharma customers will not be affected by...

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products